Results
|
|
124621.
|
|
|
|
124622.
|
|
|
|
124623.
|
|
|
|
124624.
|
|
|
|
124625.
|
|
|
|
124626.
|
|
|
|
124627.
|
Interdisciplinary decision making in prostate cancer therapy - 5-years' time trends at the Interdisciplinary Prostate Cancer Center (IPC) of the Charité Berlin. [electronic resource] by
- Baumunk, Daniel
- Reunkoff, Roman
- Kushner, Julien
- Baumunk, Alexandra
- Kempkensteffen, Carsten
- Steiner, Ursula
- Weikert, Steffen
- Moser, Lutz
- Schrader, Mark
- Höcht, Stefan
- Wiegel, Thomas
- Miller, Kurt
- Schostak, Martin
Producer: 20140317
In:
BMC medical informatics and decision making vol. 13
Availability: No items available.
|
|
|
124628.
|
|
|
|
124629.
|
Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy. [electronic resource] by
- Rajan, Prabhakar
- Sudbery, Ian M
- Villasevil, M Eugenia M
- Mui, Ernest
- Fleming, Janis
- Davis, Mark
- Ahmad, Imran
- Edwards, Joanne
- Sansom, Owen J
- Sims, David
- Ponting, Chris P
- Heger, Andreas
- McMenemin, Rhona M
- Pedley, Ian D
- Leung, Hing Y
Producer: 20150213
In:
European urology vol. 66
Availability: No items available.
|
|
|
124630.
|
|
|
|
124631.
|
|
|
|
124632.
|
Early human prostate adenocarcinomas harbor androgen-independent cancer cells. [electronic resource] by
- Fiñones, Rita R
- Yeargin, Jo
- Lee, Melissa
- Kaur, Aman Preet
- Cheng, Clari
- Sun, Paulina
- Wu, Christopher
- Nguyen, Catherine
- Wang-Rodriguez, Jessica
- Meyer, April N
- Baird, Stephen M
- Donoghue, Daniel J
- Haas, Martin
Producer: 20140807
In:
PloS one vol. 8
Availability: No items available.
|
|
|
124633.
|
|
|
|
124634.
|
A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902. [electronic resource] by
- Rosenthal, Seth A
- Hunt, Daniel
- Sartor, A Oliver
- Pienta, Kenneth J
- Gomella, Leonard
- Grignon, David
- Rajan, Raghu
- Kerlin, Kevin J
- Jones, Christopher U
- Dobelbower, Michael
- Shipley, William U
- Zeitzer, Kenneth
- Hamstra, Daniel A
- Donavanik, Viroon
- Rotman, Marvin
- Hartford, Alan C
- Michalski, Jeffrey
- Seider, Michael
- Kim, Harold
- Kuban, Deborah A
- Moughan, Jennifer
- Sandler, Howard
Producer: 20151221
In:
International journal of radiation oncology, biology, physics vol. 93
Availability: No items available.
|
|
|
124635.
|
|
|
|
124636.
|
Differential expression of the multidrug resistance 1 (MDR1) protein in prostate cancer cells is independent from anticancer drug treatment and Y box binding protein 1 (YB-1) activity. [electronic resource] by
- Saupe, Madeleine
- Rauschenberger, Lisa
- Preuß, Melanie
- Oswald, Stefan
- Fussek, Sebastian
- Zimmermann, Uwe
- Walther, Reinhard
- Knabbe, Cornelius
- Burchardt, Martin
- Stope, Matthias B
Producer: 20160719
In:
World journal of urology vol. 33
Availability: No items available.
|
|
|
124637.
|
Phase 1/2 study of orteronel (TAK-700), an investigational 17,20-lyase inhibitor, with docetaxel-prednisone in metastatic castration-resistant prostate cancer. [electronic resource] by
- Petrylak, Daniel P
- Gandhi, Jitendra G
- Clark, William R
- Heath, Elisabeth
- Lin, Jianqing
- Oh, William K
- Agus, David B
- Carthon, Bradley
- Moran, Susan
- Kong, Ning
- Suri, Ajit
- Bargfrede, Michael
- Liu, Glenn
Producer: 20160119
In:
Investigational new drugs vol. 33
Availability: No items available.
|
|
|
124638.
|
|
|
|
124639.
|
|
|
|
124640.
|
Anti-cancer effect of danshen and dihydroisotanshinone I on prostate cancer: targeting the crosstalk between macrophages and cancer cells via inhibition of the STAT3/CCL2 signaling pathway. [electronic resource] by
- Wu, Ching-Yuan
- Yang, Yao-Hsu
- Lin, Yin-Yin
- Kuan, Feng-Che
- Lin, Yu-Shin
- Lin, Wei-Yu
- Tsai, Ming-Yen
- Yang, Jia-Jing
- Cheng, Yu-Ching
- Shu, Li-Hsin
- Lu, Ming-Chu
- Chen, Yun-Ju
- Lee, Kuan-Der
- Kang, Hong-Yo
Producer: 20180402
In:
Oncotarget vol. 8
Availability: No items available.
|